Intensive chemotherapy for acute lymphoblastic leukaemia in adults.
Rohatiner
A Z
AZ
CRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK.
Bassan
R
R
Battista
R
R
Barnett
M J
MJ
Gregory
W
W
Lim
J
J
Amess
J
J
Oza
A
A
Barbui
T
T
Horton
M
M
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007558:Italy / Q000453:epidemiology; D015993:Life Tables; D015337:Multicenter Studies as Topic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D015996:Survival Rate; D006113:United Kingdom / Q000453:epidemiology; D014750:Vincristine / Q000008:administration & dosage
D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D001215:Asparaginase